申请人:Conner Eugene Scott
公开号:US20060217433A1
公开(公告)日:2006-09-28
The present invention is directed to a compound of Formula (I): and pharmaceutically acceptable salts, solvates, hydrates or stereoisomers thereof, which are useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.
本发明涉及一种式(I)化合物:及其药学上可接受的盐、溶液剂、水合物或立体异构体,可用于治疗或预防由过氧化物酶体增殖物激活受体(PPAR)介导的疾病,如 X 综合征、II 型糖尿病、高血糖、高脂血症、肥胖、凝血功能障碍、高血压、动脉硬化以及其他与 X 综合征和心血管疾病相关的疾病。